elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24193083-ED604D0D-A254-49F5-8149-7E4B8F6373C5
Q24193083-ED604D0D-A254-49F5-8149-7E4B8F6373C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24193083-ED604D0D-A254-49F5-8149-7E4B8F6373C5
Anti-vascular endothelial growth factor for diabetic macular oedema
P2860
Q24193083-ED604D0D-A254-49F5-8149-7E4B8F6373C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24193083-ED604D0D-A254-49F5-8149-7E4B8F6373C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
95777c0353f9a194f08853a8be00f4e16064b48a
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer